VV913 for premature ejaculation: a phase 2 trial
Treatments studied
Part of Kidney & urinary, Mental health clinical trials.
This trial tests if an oral capsule called VV913 can help men with premature ejaculation. You and your partner must track your sexual activity, and you will take the capsule before sex to see if it increases your time to ejaculation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 55 years old.
- You have been diagnosed with premature ejaculation (ejaculating too soon) by your doctor.
- During a 2-4 week run-in period, you had at least 4 times of vaginal sex, with ejaculation happening within 2 minutes or less in at least 3 out of 4 of those attempts.
- You scored 11 or higher on a questionnaire about premature ejaculation (PEDT).
- You have been in a stable sexual relationship with the same adult female partner for at least 3 months, and plan to stay together during the study.
- You agree to have vaginal sex at least 4 times every 28 days and to follow all study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called KH-001 to see if it can help men with lifelong premature ejaculation last longer during intercourse. It focuses on men who consistently ejaculate very quickly (within a minute) and are in a stable relationship.
This trial tests if a painless electrical nerve stimulation (TENS) treatment can help men with premature ejaculation last longer and feel more in control. It's for men who have had this condition for at least 6 months and are in a stable relationship.
This trial compares three different treatments for premature ejaculation (PE): a medication called dapoxetine (Priligy), Kegel pelvic floor exercises, and acupuncture. The aim is to see which works best and is safe.
This trial tests an herbal supplement to help men with premature ejaculation or erectile dysfunction who also have mild to moderate stress. It aims to see if the supplement can improve ejaculation time and reduce stress.
This Phase 3 study tests how well a Toronto Association treatment works for men who have both erectile dysfunction and premature ejaculation, while also checking safety. You may be able to join if your symptoms match the study targets and you can stay on a steady, stable sexual routine and relationship during the study.
This study tests whether combining two types of medications (an SSRI and a PDE5 inhibitor) works better than using just one for treating premature ejaculation. It also includes healthy volunteers as a comparison group.
Hear when a new Premature Ejaculation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.